Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DINORA study of infliximab plus methotrexate in very early inflammatory arthritis
NL-OMON31097Phase 3Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of infliximab and methotrexate in autoimmune arthritis and rheumatoid arthritis (RA) (3 arms), sponsored by Leiden University Medical Center. Started Nov 2007; status: active, not recruiting.
02
Drugs
infliximabmethotrexate
03
Conditions
autoimmune arthritisrheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON31097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31097.